Description:

Artemether Injection is an antimalarial medication used to treat severe malaria, including cerebral malaria.

Dosage Form:

Injection (intravenous or intramuscular)

Strength:

80 mg/mL (in each ampoule)

Active Ingredient:

Artemether (80 mg/mL)

Indications:

– Severe malaria (Plasmodium falciparum)

– Cerebral malaria

Contraindications:

– Hypersensitivity to artemether or artemisinin derivatives

– Severe heart conditions (e.g., QT interval prolongation)

– Pregnancy (first trimester) and lactation, unless benefits outweigh risks

– Concomitant use with other medications that prolong QT interval

Side Effects:

– Common: nausea, vomiting, diarrhea, abdominal pain, fever, headache

– Serious: allergic reactions, anaphylaxis, QT interval prolongation, neutropenia, hemolysis

Precautions:

– Monitor electrocardiogram (ECG) and blood counts

– Caution in patients with cardiac conditions, liver or kidney impairment

– Avoid concomitant use with other medications that prolong QT interval

Prescription/OTC:

Prescription-only medication

Manufacturer Information:

Varies depending on region and country; examples include:

– Cipla Limited (India)

– Ipca Laboratories Limited (India)

– Novartis Pharmaceuticals (Global)

Country of Origin:

Varies depending on manufacturer; primarily India and China

Category of Drug:

Antimalarial (Antiprotozoal)